Pulmonary Rehabilitation for Post-Lobectomy Patients

Introduction to Pulmonary Rehabilitation

The American Thoracic Society recommends pulmonary rehabilitation as the first-line intervention for post-lobectomy patients with declining TLCO, stable KCO, and worsening breathlessness and fatigue, to address physiological changes and symptom burden while improving quality of life 1

Perform full pulmonary function tests, including spirometry (FEV1, FVC), lung volumes, TLCO and KCO measurements, and oxygen saturation at rest and with exertion, to assess lung function and guide management 1
Conduct shuttle walk test or formal cardiopulmonary exercise testing to assess exercise capacity and identify exercise-induced desaturation (>4% drop in SaO2), which indicates higher risk 1
Measure peak oxygen consumption (VO2peak), with values <15 ml/kg/min indicating high risk 1
Interpret lung function tests considering factors such as altitude and technique variations, as recommended by the American Thoracic Society and European Respiratory Society 2, 3
Use the following severity classification for DLCO, as recommended by the European Respiratory Society:
Severity Percentage of Predicted
Mild >60% predicted and <LLN
Moderate 40-60% predicted
Severe <40% predicted

A structured exercise training and education program, such as the one recommended by the European Respiratory Society, can improve exercise capacity, reduce breathlessness, and address fatigue in post-lobectomy patients 4
The program should include a 6-12 week supervised program, combination of endurance and strength training, breathing techniques, and energy conservation strategies 4

Repeat pulmonary function tests, including TLCO and KCO, every 3-6 months to monitor lung function and adjust management as needed 4
Track exercise capacity with regular shuttle walk tests and monitor symptoms using validated questionnaires (e.g., mMRC dyspnea scale) 4
Adjust TLCO and KCO interpretations for hemoglobin and carboxyhemoglobin concentrations, as noted by the European Respiratory Society 3
Recognize patterns of TLCO and KCO to guide diagnosis and treatment, such as:

KCO and VA values are essential for understanding the clinical implications of DLCO and for accurate diagnosis and treatment of lung diseases, as emphasized by the European Respiratory Society 3
Long's coefficient (KCO) represents the diffusing capacity for carbon monoxide per unit of alveolar volume, calculated as KCO = DLCO/VA, providing critical information about gas exchange efficiency that complements standard pulmonary function tests, according to the European Respiratory Journal 3
Avoid misinterpreting normal KCO in restrictive disorders, failing to adjust for hemoglobin, overlooking VA measurement, and ignoring technical factors, as warned by the European Respiratory Society 3